Skip to content
10-Q

Quarterly Report

Dermata Therapeutics, Inc. DRMA DRMAW

0001641172-25-023572

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 11, 2025 681.56K sh
Shares Diluted Q2 2025 · Jun 30, 2025 1.03M sh
Shares Diluted Q2 2025 · Jun 30, 2025 772.4K sh
Shares Diluted Q2 2025 · Jun 30, 2024 67.65K sh
Shares Diluted Q2 2025 · Jun 30, 2024 56.03K sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$4.62M
Operating Cash Flow Q2 2025 · Dec 31, 2024 −$11.1M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$4.83M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $6.48M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $3.16M
Stockholders Equity Q2 2025 · Jun 30, 2025 $5.61M
Stockholders Equity Q2 2025 · Mar 31, 2025 $7.3M
Stockholders Equity Q2 2025 · Dec 31, 2024 $1.56M
Stockholders Equity Q2 2025 · Jun 30, 2024 $3.32M
Stockholders Equity Q2 2025 · Mar 31, 2024 $3.81M
Stockholders Equity Q2 2025 · Dec 31, 2023 $6.36M
Total Liabilities Q2 2025 · Jun 30, 2025 $1.03M
Total Liabilities Q2 2025 · Dec 31, 2024 $1.97M
Total Assets Q2 2025 · Jun 30, 2025 $6.64M
Total Assets Q2 2025 · Dec 31, 2024 $3.53M
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.66
Eps Diluted Q2 2025 · Jun 30, 2025 −$5.18
Eps Diluted Q2 2025 · Jun 30, 2024 −$41.82
Eps Diluted Q2 2025 · Jun 30, 2024 −$106.44
Eps Basic Q2 2025 · Jun 30, 2025 −$1.66
Eps Basic Q2 2025 · Jun 30, 2025 −$5.18
Eps Basic Q2 2025 · Jun 30, 2024 −$41.82
Eps Basic Q2 2025 · Jun 30, 2024 −$106.44
Rd Expense Q2 2025 · Jun 30, 2025 $617.84K
Rd Expense Q2 2025 · Jun 30, 2025 $1.9M
Rd Expense Q2 2025 · Jun 30, 2024 $2.01M
Rd Expense Q2 2025 · Jun 30, 2024 $3.61M
Net Income Q2 2025 · Jun 30, 2025 −$1.7M
Net Income Q2 2025 · Jun 30, 2025 −$4M
Net Income Q2 2025 · Mar 31, 2025 −$2.3M
Net Income Q2 2025 · Jun 30, 2024 −$2.83M
Net Income Q2 2025 · Jun 30, 2024 −$5.96M
Net Income Q2 2025 · Mar 31, 2024 −$3.13M
Operating Income Q2 2025 · Jun 30, 2025 −$1.77M
Operating Income Q2 2025 · Jun 30, 2025 −$4.11M
Operating Income Q2 2025 · Jun 30, 2024 −$2.88M
Operating Income Q2 2025 · Jun 30, 2024 −$6.09M